Thrombopoietin and platelet function

Seminars in Thrombosis and Hemostasis

Volumn 32, Issue 3, 2006, Pages 295-304

  Akkerman, Jan Willm N ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adhesion; Aggregation; Hematopoietic progenitor; Janus kinase; Megakaryocytes; Platelets; Priming; Protein kinase B; Ras; Secretion; Signaling; Stat; Thrombopoietin

Indexed keywords

ADENOSINE DIPHOSPHATE; JANUS KINASE; PROTEIN KINASE B; THROMBIN; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR;

APOPTOSIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; DNA SYNTHESIS INHIBITION; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; MEGAKARYOCYTE; ONCOGENE RAS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION;

BLOOD PLATELETS; HUMANS; MEGAKARYOCYTES; SIGNAL TRANSDUCTION; THROMBOPOIETIN;

EID: 33646468244     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-939442     Document Type: Review

References (35)

1. Kuter DJ, Begley CG. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood 2002;100:3457-3469
2. Feese MD, Tamada T, Kato Y, et al. Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment. Proc Natl Acad Scii USA 2004;101:1816-1821
3. Fishley B, Alexander WS. Thrombopoietin signalling in physiology and disease. Growth Factors 2004;22:151-155
4. Kaushansky K. Thrombopoietin: a tool for understanding thrombopoiesis. J Thromb Haemost 2003;1:1587-1592
5. Kaushansky K. Etiology of the myeloproliferative disorders: the role of thrombopoietin. Semin Hematol 2003;40:6-9
6. Kaushansky K. On the molecular origins of the chronic myeloproliferative disorders: it all makes sense. Blood 2005;105:4187-4190
7. Royer Y, Staerk J, Costuleanu M, Courtoy PJ, Constantinescu SN. Janus kinases affect thrombopoietin receptor cell surface localization and stability. J Biol Chem 2005;280:27251-27261
8. Le Roith D, Nissley P. Knock your SOCS off! J Clin Invest 2005;115:397-406
9. Gurney AL, Wong SC, Henzel WJ, de Sauvage FJ. Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-Stat signal transduction pathway and She phosphorylation. Proc Natl Acad Sci USA 1995;92:5292-5296
10. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004;68:320-324
11. Kamata T, Pritchard CA, Leavitt AD. Raf-1 is not required for megakaryocytopoiesis or TPO-induced ERK phosphorylation. Blood 2004;103:2568-2570
12. Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol 2005;6:322-327
13. Kirito K, Fox N, Kaushansky K. Thrombopoietin stimulates Hoxb4 expression: an explanation for the favorable effects of TPO on hematopoietic stem cells. Blood 2003;102:3172-3178
14. 2+ signalling in human megakaryocytes. Thromb Haemost 2001;86:1106-1113
15. Den Dekker E, Gorter G, Heemskerk JWM, Akkerman JWN. Development of platelet inhibition by cAMP during megakaryocytopoiesis. J Biol Chem 2002;277:29321-29329
16. Debili N, Wendung F, Cosman D, et al. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 1995;85:391-401
17. Shock DD, He K, Wencel-Drake JD, Parise LV. Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C. Biochem J 1997;321:525-530
18. Miyakawa Y, Oda A, Druker BJ, et al. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and She in human blood platelets. Blood 1995;86:23-27
19. Miyakawa Y, Oda A, Druker BJ, et al. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. Blood 1996;87:439-446
20. Chen J, Herceg-Harjacek L, Groopman JE, Grabarek J. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood 1995;86:4054-4062
21. Li J, Xia Y, Kuter DJ. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia. Br J Haematol 2000;111:943-953
22. Van Willigen G, Gorter G, Akkerman JWN. Thrombopoietin increases platelet sensitivity to α-thrombin via activation of the ERK2-cPLA2 pathway. Thromb Haemost 2000;83:610-616
23. Chen J, De S, Damron DS, Chen WS, Hay N, Byzova TV. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 2004;104:1703-1710
24. Van Os E, Wu Y, Pauwels JG, et al. Thrombopoietin increases platelet adhesion under flow conditions and decreases rolling. Br J Haematol 2003;121:482-490
25. Harker LA, Marzec UM, Hunt P, et al. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in non-human primates. Blood 1996;88:511-521
26. Harker LA, Hunt P, Marzec UM, et al. Regulation of platelet production and function by megakaryocyte growth and development factor in non-human primates. Blood 1996;87:1833-1844
27. Campus F, Lova P, Bertoni A, Sinigaglia F, Balduini C, Torti M. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin αIIbβ3 activation and platelet aggregation. J Biol Chem 2005;280:24386-24395
28. Kroner C, Eybrechts K, Akkerman JWN. Dual regulation of platelet protein kinase B. J Biol Chem 2000;275:27790-27798
29. Andrade Ferreira I, Mocking AIM, Urbanus R, Varlack S, Wnuk M, Akkerman JWN. Glucose uptake via GLUT3 in human platelets is regulated via protein kinase B. J Biol Chem 2005;280:32625-32633
30. Verhoeven AJM, Mommersteeg-Leautaud ME, Akkerman JWN. Quantification of energy consumption in platelets during thrombin-induced aggregation and secretion. Tight coupling between platelet responses and the increment in energy consumption. Biochem J 1984;221:777-787
31. Verhoeven AJM, Mommersteeg ME, Akkerman JWN. Balanced contribution of glycolytic and adenylate pool in supply of metabolic energy in platelets. J Biol Chem 1985;260:2621-2624
32. Phillips DR, Conley PB, Sinha U, Andre P. Therapeutic approaches in arterial thrombosis. J Thromb Haemost 2005;3:1577-1589
33. Hackeng CM, Relou I, Pladet MW, van Rijn HJM, Akkerman JWN. Early platelet activation by Low Density Lipoprotein via p38 mapkinase. Thromb Haemost 1999;82:1749-1756
34. James C, Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005;434:1144-1148
35. Gorter G, Akkerman JWN. Serine-threonine kinases. In: Gibbins JM, Mahaut-Smith MP, eds. Methods in Molecular Biology 273: Platelets and Megakaryocytes. Totowa, NJ: Humana Press; 2004:179-199